Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
(Net loss) income	$ (21,649)	$ (16,224)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	153	179
Stock-based compensation	4,191	3,024
Change in fair value of warrant liability	(1,800)	(10,390)
Amortization of debt discount and issuance costs	832	825
Changes in operating assets and liabilities:
Accounts receivable	(1,069)	11,804
Prepaid expenses and other assets	(746)	1,856
Inventory	(3,356)	1,672
Accounts payable	(2,153)	1,191
Accrued expenses and other liabilities	(12,122)	(16,953)
Cash used in operating activities	(37,719)	(23,016)
Investing activities:
Purchases of property and equipment	(51)	(79)
Cash used in investing activities	(51)	(79)
Financing activities:
Proceeds from sale of common stock and warrants	55,476	0
Proceeds from issuance of common stock under employee stock purchase plan	165	164
Cash paid for financing costs	(198)	(3)
Cash provided by financing activities	55,443	161
Net increase (decrease) in cash, cash equivalents and restricted cash	17,673	(22,934)
Cash and cash equivalents at beginning of period	73,684	94,244
Cash and cash equivalents at end of period	91,358	71,310
Supplemental disclosure of cash flow information:
Cash paid for interest	13,745	8,656
Supplemental disclosure of noncash activities:
Recognition of right-of-use assets and lease liabilities	$ 1,402	$ 221